+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: Position of the GUM working group on the in vitro micronucleus test



Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: Position of the GUM working group on the in vitro micronucleus test



Mutation Research 410(1): 81-116



In order to license a pharmaceutical or chemical, a compound has to be tested for several genotoxicity endpoints, including the induction of chromosomal aberrations in vitro. A working group within the GUM has evaluated published data on the in vitro micronucleus test with the aim of judging its suitability as a replacement for the in vitro chromosomal aberration test. After strict rejection criteria were applied, a database including 96 publications and 34 compounds was obtained. For 30 of these compounds, data on both tests were available. For 24 of the 30, concordant results in both test systems were obtained (80% correlation). The discordant results in 6 compounds can be explained by a known or suspected aneugenic potential of these compounds. Considering that cell types and test protocols were extremely heterogeneous, this correlation is rather encouraging. Comparison of the different protocols, and experience established within the working group yielded several recommendations for the routine use of the in vitro micronucleus test. Although many cell lines are suitable, those most often used in genotoxicity testing (e.g. CHL, CHO, V79, human lymphocytes, L5178Y mouse lymphoma cells) are recommended. Cytochalasin B may be used in the case of human lymphocytes; however, the possibility of its interaction with aneugenic test compounds should be considered. For continuously dividing cell lines, cytochalasin B is not recommended by the working group. Although, there seems to be flexibility in the choice of treatment and sampling times, the average generation time of the chosen cell line of choice should be taken into account when determining sampling time, and treatment of cells for at least one cell cycle duration is recommended. The use of appropriate cytotoxicity tests is strongly recommended. Although studies on some parameters of the test protocol may be useful, the introduction of the in vitro micronucleus test into genotoxicity testing and guidelines should not be delayed. Even in its present state, the in vitro micronucleus is a reliable genotoxicity test. Compared with the chromosomal aberration test, it detects aneugens more reliably, it is faster and easier to perform, and it has more statistical power and the possibility of automation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008638203

Download citation: RISBibTeXText

DOI: 10.1016/s1383-5742(97)00030-6


Related references

Evaluation of the in vitro micronucleus test using Chinese hamster lung (CHL) cells as an alternative to the chromosomal aberration test. Mutation Research/Environmental Mutagenesis and Related Subjects 272(3): 271-272, 1992

Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutation Research. 272(3): 223-236, 1992

In vitro micronucleus test as replacement for the in vitro chromosomal aberration assay Industrial experience. Environmental & Molecular Mutagenesis 31(SUPPL 29): 2, 1998

Evaluation of the in vitro micronucleus test as a pre-screen for the in vitro chromosome aberration assay Comparison of results from the two tests. Environmental & Molecular Mutagenesis 31(SUPPL 29): 4, 1998

Genetic toxicity assessment: employing the best science for human safety evaluation. Part II: Performances of the in vitro micronucleus test compared to the mouse lymphoma assay and the in vitro chromosome aberration assay. Toxicological Sciences 96(2): 214-217, 2006

Cytosine arabinoside, vinblastine, 5-fluorouracil and 2-aminoanthracene testing in the in vitro micronucleus assay with L5178Y mouse lymphoma cells at Sanofi Aventis, with different cytotoxicity measurements, in support of the draft OECD Test Guideline on In Vitro Mammalian Cell Micronucleus Test. Mutation Research 702(2): 148-156, 2011

Investigation of soy sauce treated with nitrite in the chromosomal aberration test in vitro and the micronucleus test in vivo. Mutation Research 262(3): 171-176, 1991

Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test. Bmc Complementary and Alternative Medicine 14: 215, 2014

Comparative evaluation of the in vitro micronucleus test and the in vivo chromosome aberration test: Industrial experience. Mutation Research 392(1-2): 45-49, 1997

Evaluation of the micronucleus test in vitro using Chinese hamster cells; Results of four chemicals weakly positive in the in vivo micronucleus test. Environmental & Molecular Mutagenesis. 26(3): 240-247, 1995

Studies for a genotoxic potential of some endogenous and exogenous sex steroids. II. Communication: examination for the induction of cytogenetic damage using the chromosomal aberration assay on human lymphocytes in vitro and the mouse bone marrow micronucleus test in vivo. Environmental and Molecular Mutagenesis 28(2): 133-144, 1996

Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagenesis 14(1): 5-22, 1999

Cytotoxicity measurement in in vitro chromosome aberration test and micronucleus test. Mutation Research 724(1-2): 86-87, 2011

Correlation between the micronucleus test in vitro and the chromosome aberration test in CHO-K1 cells. Mutagenesis 7(5): 374, 1992

In vitro chromosome aberration test and in vivo micronucleus test of Ca-type Garcinia extract. Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan 47(2): 80-84, 2006